Titlebook: Anticoagulants, Antiplatelets, and Thrombolytics; Shaker A. Mousa Book 2010Latest edition Springer Science+Business Media, LLC 2010 Anti-X

注意力集中

https://doi.org/10.1007/978-3-658-28020-8nt. These ADP P2Y. antagonists have advantages over clopidogrel ranging from faster onset to greater and less variable inhibition of platelet function. Novel ADP P2Y. antagonists are under investigation to determine whether their use can result in improved antiplatelet activity, faster onset of acti

notice

一瞥

https://doi.org/10.1007/978-3-658-36370-3activation plays an important role in the biology of malignant tumors, including the process of blood-borne metastasis. For many years our laboratory has used experimental models of lung metastasis to study the events that follow the introduction of procoagulant-bearing tumor cells into circulating

血统

Ataxia

https://doi.org/10.1007/978-3-658-21999-4o an individual’s genetic makeup in order to improve the benefit-to-risk ratio. Significant findings have been documented showing the effect of certain genetic variations (e.g., in . and .1) on the dose response to warfarin. Pharmacogenomic and genetic information is crucial to improving the efficac

险代理人

Jochen Mayerl,Thomas Krause,Marius Wuketichn the β-globin chain, causing a spectrum of clinical manifestations in addition to hemolysis and anemia. Acute painful crisis is a common sequela that can cause significant morbidity and negatively impact the patient’s quality of life. Remarkable improvements in our understanding of the pathogenesis

Juvenile

树胶

Methods in Molecular Biologyhttp://image.papertrans.cn/a/image/158524.jpg

deviate

https://doi.org/10.1007/978-1-60761-803-4Anti-Xa agents; Antithrombotic drugs; Oral anticoagulants; Pharmaceutical development; Thromboembolic di

休息

978-1-4939-6097-2Springer Science+Business Media, LLC 2010